These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9303225)
41. [Safety of new antihistamines]. Kruszewski J Pol Merkur Lekarski; 2003 Jun; 14(84):647-50. PubMed ID: 14524292 [TBL] [Abstract][Full Text] [Related]
42. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis. Lee J; Cummins G; Okamoto L Am J Manag Care; 2001 May; 7(4 Suppl):S103-12. PubMed ID: 11392821 [TBL] [Abstract][Full Text] [Related]
43. Safety of antihistamines during pregnancy and lactation. So M; Bozzo P; Inoue M; Einarson A Can Fam Physician; 2010 May; 56(5):427-9. PubMed ID: 20463270 [TBL] [Abstract][Full Text] [Related]
44. Antihistamines in clinical practice. Time for a reappraisal. Sutherland D Aust Fam Physician; 1985 Jun; 14(6):501-7. PubMed ID: 2862858 [No Abstract] [Full Text] [Related]
46. The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis. Etwel F; Faught LH; Rieder MJ; Koren G Drug Saf; 2017 Feb; 40(2):121-132. PubMed ID: 27878468 [TBL] [Abstract][Full Text] [Related]
47. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday. Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555 [TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetic overview of oral second-generation H1 antihistamines. González MA; Estes KS Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995 [TBL] [Abstract][Full Text] [Related]
49. Risk of selected serious cardiac events among new users of antihistamines. Staffa JA; Jones JK; Gable CB; Verspeelt JP; Amery WK Clin Ther; 1995; 17(6):1062-77. PubMed ID: 8750398 [TBL] [Abstract][Full Text] [Related]